Exploring the effects of overexpression of HCLS1, EV12B, and CD48 genes in reducing migration, proliferation, and invasion of CRC cells and eventually suppressing CRC tumor growth could provide us with promising CRC therapies [90]. Here, CD48 is linked to colorectal carcinoma.